[1]刘俊,张永强,李晓芳,等.不同剂量瑞马唑仑对腹横肌平面阻滞下行腹膜透析置管术肾衰竭患者的镇静效果比较[J].新乡医学院学报,2023,40(10):926-931.[doi:10.7683/xxyxyxb.2023.10.004]
　LIU Jun,ZHANG Yongqiang,LI Xiaofang,et al.Comparison of sedation effect of different doses of ramazolam on renal failure patients undergoing peritoneal dialysis catheterization under transversus abdominis plane block[J].Journal of Xinxiang Medical University,2023,40(10):926-931.[doi:10.7683/xxyxyxb.2023.10.004]
点击复制

不同剂量瑞马唑仑对腹横肌平面阻滞下行腹膜透析置管术肾衰竭患者的镇静效果比较
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年10
页码:
926-931
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Comparison of sedation effect of different doses of ramazolam on renal failure patients undergoing peritoneal dialysis catheterization under transversus abdominis plane block
作者:
刘俊1; 张永强1; 李晓芳1; 孙俊娜1; 赵际平1; 王云2; 岳修勤1
（1．新乡医学院第一附属医院麻醉与围术期医学科，河南　卫辉　453100；2.新乡医学院第一附属医院肾脏病医院二病区，河南　卫辉　453100）
Author(s):
LIU Jun1; ZHANG Yongqiang1; LI Xiaofang1; SUN Junna1; ZHAO Jiping1; WANG Yun2; YUE Xiuqin1
(1.Department of Anesthesiology and Perioperative Medicine,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China;2.The Second Ward,Kidney Disease Hospital of the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China )
关键词:
瑞马唑仑; 腹横肌平面阻滞; 肾衰竭; 腹膜透析置管术; 镇静
Keywords:
remazolam; transversus abdominis plane block; renal failure; peritoneal dialysis catheterization; sedation
分类号:
R692.5
DOI:
10.7683/xxyxyxb.2023.10.004
文献标志码:
A
摘要:
目的　比较不同剂量瑞马唑仑对腹横肌平面阻滞(TAPB)下行腹膜透析置管术肾衰竭患者的镇静效果。
方法　选择2021年4月至2022年8月于新乡医学院第一附属医院择期行腹膜透析置管术的120例肾衰竭患者为研究对象，根据治疗方法将患者分为低剂量组、中剂量组、高剂量组、对照组，每组30例。所有患者于术前行 TAPB，TAPB完成后15 min，低剂量组、中剂量组、高剂量组患者静脉注射瑞马唑仑0.075 mg·kg-1，随即分别以 0.2、0.4、0.6 mg·kg-1·h-1剂量维持静脉泵注；对照组患者静脉注射10 g·L-1丙泊酚0.5 mg·kg-1，随即以2 mg·kg-1·h-1 剂量维持泵注。分别于手术切皮时（T1）、分离皮下组织时（T2）、牵拉及切开腹膜时（T3）、放置腹膜透析管时（T4）、打皮下隧道时（T5）及手术结束时（T6），采用视觉模拟评分法（VAS）评估各组患者的疼痛程度。分别于入室后5 min（T0）、T1、T2、T3、T4、T5、T6时，记录各组患者的平均动脉压（MAP）和心率（HR）。分别于T1、T2、T3、T4、T5、T6时，采用改良警觉镇静（MOAA/S）评分评估各组患者的镇静水平。记录各组患者苏醒时间，苏醒时间为瑞马唑仑或丙泊酚停药后至MOAA/S评分达到5分的时间。记录各组患者术中呼吸抑制（呼吸频率<6次·min-1或呼吸暂停时间>20 s）发生次数，并计算术中呼吸抑制发生率。记录各组患者术后24 h内头晕、嗜睡、恶心、呕吐等不良反应发生情况。
结果　T1～T6时，4组患者的VAS评分比较差异无统计学意义（P>0.05）。T1～T5时，低剂量组、中剂量组、高剂量组患者的MAP均显著高于对照组（P<0.05）；T1～T5时，低剂量组、中剂量组、高剂量组患者的MAP比较差异无统计学意义（P>0.05）；T0、T6时，4组患者的MAP比较差异无统计学意义（P>0.05）。T0～T6时，4组患者的HR比较差异无统计学意义（P>0.05）。T1～T6时，高剂量组患者的MOAA/S评分显著低于对照组、低剂量组、中剂量组（P<0.05）；T1～T6时，对照组、低剂量组、中剂量组患者的MOAA/S评分比较差异无统计学意义（P>0.05）。高剂量组患者的苏醒时间显著长于对照组、低剂量组、中剂量组（P<0.05）；对照组、低剂量组、中剂量组患者的苏醒时间比较差异无统计学意义（P>0.05）。对照组患者的术中呼吸抑制发生率显著高于低剂量组、中剂量组、高剂量组（P<0.05）；低剂量组、中剂量组、高剂量组患者的术中呼吸抑制发生率比较差异无统计学意义（P>0.05）。4组患者术后头晕、嗜睡及恶心、呕吐不良反应发生率比较差异无统计学意义（P>0.05）。
结论　以0.2、0.4 mg·kg-1·h-1剂量持续泵注瑞马唑仑可安全、有效应用于TAPB下行腹膜透析置管术肾衰竭患者术中镇静。
Abstract:
Objective　To compare the sedative effect of different doses of remazolam on renal failure patients undergoing peritoneal dialysis catheterization under transversus abdominis plane block (TAPB).
Methods　A total of 120 patients with renal failure who underwent peritoneal dialysis catheterization at the First Affiliated Hospital of Xinxiang Medical University from April 2021 to August 2022 were selected as the research subjects.According to the treatment methods,the patients were divided into the low-dose group,medium-dose group,high-dose group and control group,with 30 cases in each group.All patients underwent TAPB before surgery.At 15 minutes after the completion of TAPB,patients in the low-dose group,medium-dose group and high-dose group received intravenous injection of 0.075 mg · kg-1 of ramazolam,and then maintained intravenous infusion at a dose of 0.2,0.4,0.6 mg · kg-1 · h-1,respectively;the patients in the control group received intravenous injection of 10 g · L-1 propofol at a dose of 0.5 mg · kg-1,followed by maintenance of pump infusion at a dose of 2 mg · kg-1 · h-1.At the time of surgical skin incision (T1),subcutaneous tissue separation (T2),peritoneal traction and incision (T3),peritoneal dialysis tube placement (T4),subcutaneous tunneling (T5) and surgical end (T6),the pain level of patients in each group was evaluated by the visual analog scale (VAS) method.The mean arterial pressure (MAP) and heart rate (HR) of patients in each group were recorded at 5 min after entry (T0),T1,T2,T3,T4,T5 and T6.At T1,T2,T3,T4,T5 and T6,the sedation level of patients in each group was evaluated by the modified observer′s assessment of alert /sedation (MOAA/S) score.The awakening time of patients in each group was recorded,which was the time from the cessation of medication with remidazolam or propofol until the MOAA/S score reached 5 scores.The number of occurrences of intraoperative respiratory suppression (respiratory rate<6 times per minute or apnea time>20 s) in each group of patients was recorded,and the incidence of intraoperative respiratory suppression was calculated.The occurrence of adverse reactions including dizziness,drowsiness,nausea,vomiting within 24 h after surgery in each group of patients was recorded.
Results　At T1 to T6,there was no significant difference in VAS scores of patients among the four groups (P>0.05).At T1 to T5,the MAP of patients in the low-dose group,medium-dose group and high-dose group was significantly higher than that in the control group (P<0.05);at T1 to T5,there was no significant difference in MAP of patients among the low-dose group,medium-dose group and high-dose group (P>0.05);at T0 and T6,there was no significant difference in MAP of patients among the four groups (P>0.05).At T0 to T6,there was no significant difference in HR of patients between the four groups (P>0.05).At T1 to T6,the MOAA/S score of patients in the high-dose group was significantly lower than that in the control group,low-dose group,medium-dose group (P<0.05);at T1 to T6,there was no significant difference in the MOAA/S score of patients among the control group,low-dose group,medium-dose group (P>0.05).The awakening time of patients in the high-dose group was significantly longer than that in the control group,low-dose group and medium-dose group (P<0.05);there was no significant difference in the recovery time of patients among the control group,low-dose group and medium-dose group (P>0.05).The incidence of intraoperative respiratory depression of patients in the control group was significantly higher than that in the low-dose group,medium-dose group and high-dose group (P<0.05);there was no significant difference in the incidence of intraoperative respiratory suppression of patients among the low-dose group,medium-dose group and high-dose group(P>0.05);there was no significant difference in the incidence of postoperative dizziness,drowsiness,nausea and vomiting of patients among the four groups (P>0.05).
Conclusion　Remazolam continuous infusion at a dose of 0.2,0.4 mg · kg-1 · h-1 is safe and effective for intraoperative sedation in renal failure patients undergoing peritoneal dialysis catheterization under TAPB.

参考文献/References:

［1］　陈瑜,蔡姝,朱晓刚,等.瑞马唑仑用于老年患者全麻诱导时的镇静效果［J］.中华麻醉学杂志,2020,40(8):974-976.
CHEN Y,CAI Z,ZHU X G,et al.Sedative effect of remimazolam for induction of general anesthesia in elderly patients［J］.Chin J Anesthesiol,2020,40(8):974-976.
［2］　王春艳,于泳浩.瑞马唑仑临床研究进展［J］.中华麻醉学杂志,2019,39(3):261-263.
WANG C Y,YU Y H.Progress in clinical research on remimazolam［J］.Chin J Anesthesiol,2019,39(3):261-263.
［3］　LEVEY A S,ECKARDT K U,DORMAN N M,et al.Nomenclature for kidney function and disease:report of a kidney disease:Improving Global Outcomes (KDIGO) consensus conference［J］.Kidney Int,2020,97(6):1117-1129.
［4］　APFELBAUM J L,CONNIS R T.The American society of anesthesiologists practice parameter methodology［J］.Anesthesiology,2019,130(3):367-384.
［5］　胡正权,李娜,刘杰等.右美托咪定复合罗哌卡因腹横肌平面阻滞在腹膜透析置管术中的效果［J］.临床麻醉学杂志,2020,36(2):120-123.
HU Z Q,LI N,LIU J,et al.Effect of combination of dexmedetomidine and ropivacaine injection by transversus abdominis plane block for peritoneal dialysis catheter placement［J］.J Clin Anesthesiol,2020,36(2):120-123.
［6］　中华医学会麻醉学分会区域麻醉镇静管理专家共识工作小组.区域麻醉镇静管理专家共识［J］.中华麻醉学杂志,2017,37(1):12-20.
EXPERT CONSENSUS WORKING GROUP OF REGIONAL ANESTHESIA SEDATION MANAGEMENT OF CHINESE ANESTHESIOLOGY ASSOCIATION.Consensus on sedation during regional anesthesia［J］.Chin J Anesthesiol,2017,37(1):12-20.
［7］　尹飞挺．腹膜透析治疗的现状及挑战［J］．肾脏病与透析肾移植杂志,2015,24（2）：186-189
YIN F T.Peritoneal dialysis opportunity and challenge［J］.J Nephrol Dialy Transplant,2015,24（2）:186-189.
［8］　蔡畅,漆勇,李炎,等.腹横肌平面阻滞联合腹直肌鞘阻滞在腹膜透析置管术中的应用［J］.中华肾脏病杂志,2017,33(9):686-690.
CAI C,QI Y,LI Y,et al.Application of transversus abdominis plane block combined with rectus sheath block for peritoneal dialysis［J］.Chin J Nephrol,2017,33(9):686-690.
［9］　BORKETT K M,RIFF D S,SCHWARTZ H I,et al.A Phase Ila,randomized,double-blind study of remimazolam (CNS7056) versus midazolam for sedation in upper gastrointestinal endoscopy［J］.Anesth Analg,2015,120(4):771-780.
［10］　WESOLOWSKI A M,ZACCAGNINO M P,MALAPERO R J,et al.Remimazolam:pharmacologic considerations and clinical role in anesthesiology［J］.Pharmacotherapy,2016,36(9):1021-1027.
［11］　刘颜.瑞马唑仑衍生物的设计合成及其生物活性研究［D］.重庆:重庆医科大学，2016.
LIU Y.Design synthesis and biological evaluation of remimazolam derivatives［D］.Chongqing:Chongqing Medical University,2016.
［12］　FREYER N,KNOSPEL F,DAMM G,et al.Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system［J］.Drug Des Devel Ther,2019,13:1033-1047
［13］　PASTIS N J,YARMUS L B,SCHIPPERS F,et al.Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy［J］.Chest,2019,155(1):137-146.
［14］　DOI M,MORITA K,TAKEDA J,et al.Efficacy and safety of remimazolam versus propofol for general anesthesia：a multicenter，single-blind,randomized,parallel-group,phase Ⅱb/Ⅲ trial ［J］.J Anesth,2020,34(4):543-553.
［15］　肖兴鹏,郭明,马岚,等.瑞马唑仑-丙泊酚-舒芬太尼用于无痛胃镜检查术患者麻醉的效果［J］.中华麻醉学杂志,2021,41(2):192-194.
XIAO X P,GUO M,MA L,et al.Efficacy of remimazolam-propofol-sufentanil for anesthesia in patients undergoing painless gastroscopy［J］.Chin J Anesthesiol,2021,41(2):192-194.
［16］　ANTONIK L J,GOLDWATER D R,KILPATRICK G J,et al.A placebo and midazolam-controlled phase I single ascending-dose study evaluating the safety,pharmacokinetics,and pharmacodynamics of remimazolam (CNS 7056):Part I.Safety,efficacy,and basic pharmacokinetics［J］.Anesth Analg,2012,115(2):274-283.
［17］　WILTSHIRE H R,KILPATRICK G J,TILBROOK G S,et al.A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety,pharmacokinetics,and pharmacodynamics of remimazolam (CNS 7056):Part II.Population pharmacokinetic and pharmacodynamic modeling and simulation［J］.Anesth Analg,2012,115(2):284-296.

相似文献/References:

[1]任柏林,冯爱敏,乔迎帅,等.腰方肌与腹横肌平面阻滞在腹腔镜手术中的镇痛效果比较[J].新乡医学院学报,2018,35(8):719.[doi:10.7683/xxyxyxb.2018.08.018]
　REN Bo-lin,FENG Ai-min,QIAO Ying-shuai,et al.Comparison of the analgesic effect between quadratus lumborum block and transversus abdominis plane block in laparoscopic operation[J].Journal of Xinxiang Medical University,2018,35(10):719.[doi:10.7683/xxyxyxb.2018.08.018]
[2]王卫华,杨红军,王尚柯,等.超声引导下腹横肌平面阻滞与腰方肌阻滞在腹腔镜子宫肌瘤剔除术中的应用效果比较[J].新乡医学院学报,2022,39(2):182.[doi:10.7683/xxyxyxb.2022.02.017]
　WANG Weihua,YANG Hongjun,WANG Shangke,et al.Comparison of the application effect of ultrasound-guided transversus abdominis plane block and quadratus lumborum block in laparoscopic myomectomy[J].Journal of Xinxiang Medical University,2022,39(10):182.[doi:10.7683/xxyxyxb.2022.02.017]
[3]张红伟,王卫卫,李晓芳,等.罗哌卡因联合右美托咪定腹横肌平面阻滞对腹腔镜胃癌根治术患者术后应激激素及认知功能的影响[J].新乡医学院学报,2024,(3):245.[doi:10.7683/xxyxyxb.2024.03.009]
　ZHANG Hongwei,WANG Weiwei,LI Xiaofang,et al.Effect of ropivacaine combined with dexmedetomidine in transversus abdominis plane block on postoperative stress hormone and cognitive function in patients undergoing laparoscopic radical gastrectomy[J].Journal of Xinxiang Medical University,2024,(10):245.[doi:10.7683/xxyxyxb.2024.03.009]

更新日期/Last Update: 2023-10-05